Press release
Protheragen's FLEXFlash Platform Powers Up Next-Generation Pet Supplement Development by Offering OEM and ODM Services
Protheragen has launched its pet supplement OEM and ODM services anchored by its proprietary FLEXFlash platform, ushering in a new era of advanced, consumer-centric pet supplements.As pet owners worldwide become more health-oriented towards their companions, the global pet supplement market is booming - though with some long-standing hurdles: homogenized products, inconvenient feeding procedures, and expensive, complicatedquality-checking. Taking on these challenges, Protheragen, a pioneer in pet health solutions, has launched its pet supplement OEM and ODM services [https://flexflash.protheragen.ai/] anchored by its proprietary FLEXFlash platform, ushering in a new era of advanced, consumer-centric pet supplements.
At the core of Protheragen's offering is the FLEXFlash technology, which combines low-temperaturevacuum freeze drying with rapid release formulation. This novel drying method removes moisture from active ingredients while maintaining their stability and bioactivity, andgenerates a porous framework that facilitates rapid disintegration in saliva or water. Unlike traditional supplements, FLEXFlash-powered products bypass gastrointestinal degradation and the first-pass effect, boosting bioavailability and accelerating onset. The low-moisture formula also inhibits microbial growth, eliminating the need for chemical preservatives to reduce allergy risks, while safeguarding heat-sensitive ingredients such as probiotics, enzymes, and vitamins-critical for pet health efficacy.
Backed with FLEXFlash technology, Protheragen's OEM service delivers a one-stop solution for brands, covering every stage from formula selection to finished product delivery. Leveraging over a decade of industry expertise, Protheragen can offer more than 30 scientifically validated ready-to-use formulas spanning high-demand categories: joint support, gut health, fresh breath, skin and coat care, immune system boosters, calming support, and weight management. Brands can adopt these formulas directly or customize ingredient ratios based on pet breed, age, or specific health needs, ensuring alignment with target audiences. All products are manufactured in an FDA-registered facility adhering to GMP standards, with strict quality control spanning raw material sourcing to final inspection, guaranteeing consistent safety and potency.
Complementing its OEM capabilities, Protheragen's ODM service transforms brand visions into market-ready innovations through end-to-end customization. Its expert R&D team develops exclusive formulas tailored to unique brand positioning, paired with breakthrough dosage forms that solve pet feeding struggles. These include flash-release tablets, which dissolve instantly in saliva without water or forced feeding-ideal for picky eaters, senior pets, or those with swallowing difficulties-and custom pet orally dissolving films [https://nutrapaw.protheragen.ai/custom-pet-orally-dissolving-films.html] (ODFs), which adhere to the pet's mouth and deliver precise doses in seconds. With 40+ ready-to-use ODF formulas and support for personalized labeling and packaging design, Protheragen empowers brands to stand out in a crowded market.
Protheragen's collaboration models cater to both startups and established enterprises, with scalable procurement and a mature supply chain that optimizes costs. The company's commitment to flexibility, quality, and innovation addresses the dual needs of brands-speed to market and product differentiation-while meeting pet owners' demands for safe, effective, and convenient supplements.
"As pet health evolves from a niche concern to a core consumer priority, pet supplement brands require partners that can turn ideas into impactful products," noted a Protheragen representative. "Our FLEXFlash-powered OEM and ODM services remove industry barriers, enabling brands to capitalize on market growth while putting pet wellness first." With its scientific rigor, advanced technology, and customer-centric approach, Protheragen is poised to redefine the pet supplement landscape, inviting global brands to collaborate and shape the future of pet health.
About Protheragen
Protheragen is an innovative company with FLEXFlash technology as its core competitive advantage, specializing in providing high-quality dietary supplements, pet supplements, and cosmetics. Its diverse product forms include flash-release tablets, flash-release powders, and flash-release beads, designed to meet the varying needs of different clients. With over 100 ready-to-use formulas, Protheragen can provide turnkey OEM services. If no existing formula aligns with customers' requirements, Protheragen also offers one-stop ODM services according to clients' needs.
Media Contact
Company Name: Protheragen
Contact Person: Hannah Green
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=protheragens-flexflash-platform-powers-up-nextgeneration-pet-supplement-development-by-offering-oem-and-odm-services]
Country: United States
Website: https://flexflash.protheragen.ai/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Protheragen's FLEXFlash Platform Powers Up Next-Generation Pet Supplement Development by Offering OEM and ODM Services here
News-ID: 4323118 • Views: …
More Releases from ABNewswire
Andatel Grande Patong Phuket: 40-50M THB Mold Remediation After 6-Year Coastal C …
Andatel Grande Patong Phuket addresses extensive mold damage from unprecedented six-year COVID closure (March 2023-March 2026) through comprehensive remediation program. The 122-room property invested 40-50 million Thai Baht (35% of total 120-140M budget) demolishing and rebuilding affected ceilings and walls. Coastal humidity exceeding 80% without air conditioning created severe mold penetration throughout property.
PATONG, Phuket, Thailand - February 22, 2026 - One of the best Andatel Grande Patong Phuket option in…
Best Deals on MercyMe 2026 Tour Tickets: Get Affordable Seats at CapitalCityTick …
MercyMe's Wonder + Awe Tour 2026 kicks off March 12 in Greensboro, NC, featuring hits like "I Can Only Imagine" and new tracks from their upcoming album. With special guests Big Daddy Weave, Tim Timmons, and Sam Wesley, the 24+ city spring run spans the U.S., from East Coast arenas to West Coast venues, wrapping April 25 in Spokane, WA.
MercyMe's Wonder + Awe Tour 2026 [https://www.capitalcitytickets.com/MercyMe-Tickets] is bringing an uplifting…
Upcoming Book Offers Readers a Rare Perspective, Taking Them on a Mother's Journ …
Sarah Standifird's upcoming book, Citizen's Prey, will be released on March 28 and offers a rare, unflinching look at what happens when families are forced to navigate the justice system after preventable tragedy.
With years of experience in the legal industry, Sarah Standifird once worked alongside attorneys nationwide. Now, she writes from the other side of the courtroom-as a grieving mother navigating the system as a client-offering a rare and unflinching…
Peak Grounding Sets New Industry Standard with Filtration Technology That Elimin …
"We asked ourselves why the wellness industry was accepting a 43% side effect rate as normal when other health categories would find that statistic completely unacceptable. Our filters represent a fundamental reimagining of what grounding products should deliver: pure benefits without compromise, allowing users to earth confidently and comfortably."
The grounding and earthing movement has captured the attention of wellness enthusiasts worldwide, driven by compelling research suggesting that direct connection with…
More Releases for Protheragen
Protheragen Expands 13C/14C-Labeled Compound Portfolio for Metabolic and Pharmac …
Protheragen offers a wider variety of 13C/14C-labeled compounds, supporting research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing.
New York, USA - November 12, 2025 - Protheragen has expanded its 13C/14C-labeled compound portfolio to support research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing. The expanded lineup improves options for high-accuracy molecular tracing and supports consistent data output in metabolism and drug distribution research. Researchers can now explore a…
Protheragen Introduces Comprehensive Drug Analysis Services for Pharmaceutical D …
Protheragen, a leading biotechnology company, provides effective Drug Analysis [https://www.protheragen.ai/drug-analysis.html] services that help pharmaceutical researchers and manufacturers. In drug research, drug analysis is useful for the safety, efficacy, and quality of drugs. With advanced technologies and scientific expertise, Protheragen's analytical solutions play an important role in drug development.
Drug Analysis includes many analytical procedures designed to evaluate various properties of pharmaceutical compounds. These analyses are important for understanding drug characteristics and…
Protheragen Launches One-stop Services for Rare Blood Diseases
Protheragen, a leading provider of life sciences research and development solutions, announces its innovative One-stop Services [https://www.protheragen.us/blood-disorders/our-services.html] platform designed to accelerate therapeutic discoveries and development across blood disease areas. This platform integrates advanced technologies with expert scientific consultation. The streamlined workflow can better address the challenges in research.
"Our integrated approach allows clients to handle the issues of drug development with heightened accuracy and operational efficiency," explains a senior scientist from…
Protheragen Unveils Revolutionary EndureCAR-T Trademark Cell Therapy Platform
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.
Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART Trademark technology platform, Protheragen provides investigators a wide range of disease models to ensure detailed and customized treatment methods for superior therapeutic outcomes.
With the development of immunology, scientists…
Protheragen Announces GeniusAb Trademark : A Fully Human Single-Domain Antibody …
New York, United States - Protheragen has launched GeniusAb Trademark [https://www.geniusab.com/], a fully human single-domain antibody platform to produce high quality and customized antibodies for research, diagnostic and therapeutic use. This is a major breakthrough in the field of therapeutic antibodies as it is able to provide highly specific, robust, and versatile solutions to a variety of diseases.
Single-domain antibodies (sdAbs), also known as VHH antibodies or camelid antibodies, are derived…
Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Developme …
Protheragen announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research.
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development [https://www.protheragen.us/]. These diagnostic services are designed to support the scientific community in identifying, understanding, and ultimately treating rare diseases that affect millions…
